Click here for YNHH home page.


Sign up for HealthLINK.

Can we help?

Follow up on this month's He@lthLINK

 


Phone Numbers

Directory assistance
(203) 688-4242

Patient information
(203) 688-4177

Adult emergency
(203) 688-2222

Children's emergency
(203) 688-3333

Admitting
(203) 688-2221

Children's admitting
(203) 688-3331

Psychiatric admitting
(203) 688-9907



Mailing address:
Yale-New Haven Hospital
20 York Street
New Haven, CT
06510-3202





Yale-New Haven Hospital, New Haven, Connecticut, USA HealthLINK: Women's Health

November 8, 2000

News this month
Study points to lower blood pressure target

In searching for ways to reduce the risk of heart attacks and strokes among people with high blood pressure, medical researchers studied 19,000 patients to determine what the target blood pressure should be. Are there significant health benefits to be gained from reducing blood pressure below the long-held baseline of 140/90 and at what point is the benefit highest?

Medical researchers studied 19,000 patients to determine what the target blood pressure should be.

The Hypertension Optimal Treatment (HOT) Study is one of the largest intervention trials ever completed in hypertension. It was conducted from October 1992 to August 1997 and involved 18,790 patients in 26 countries. The study also looked at the effectiveness of aspirin in helping to control hypertension. Results were published in The Lancet.

Subjects given three blood pressure targets
Participants in the study were 50 to 80 years old. They had an average diastolic blood pressure of 105 millimeters (mm) of mercury (Hg) and an average systolic blood pressure of 170 mm Hg. Forty-seven percent of the subjects were women. Because of the near equal numbers, the results of the study can be applied equally to both genders.

Results of the study can be applied equally to both genders.

Participants were randomly assigned to three groups in which the target diastolic blood pressure was 90, 85 or 80 mm Hg. About 53 percent of patients were being treated for hypertension prior to the study. All previous antihypertensive medications were stopped.

To help patients reduce their blood pressure, felodipione, a long-acting calcium channel blocker, was used. Angiotensin converting enzyme (ACE) inhibitors and beta-blockers were added to the regimen of about two-thirds of the subjects to help them attain their diastolic blood pressure goal. For the aspirin study, 9,399 patients were randomly assigned 75 mg/day of aspirin, and 9,391 were assigned a placebo.

A 30 percent reduction in events including death was observed at a mean diastolic blood pressure of 82.6.

Study findings
The lowest incidence of major cardiovascular events, a 30 percent reduction in events including death, was observed at a mean diastolic blood pressure of 82.6 mm Hg. Lowering blood pressure to 70 did not seem to give much further benefit, but it also did not pose any additional risk.

The most impressive and dramatic aspect of the study was the effect on diabetics for whom cardiovascular disease is the major cause of death. Diabetics in this study had a 2.5 times greater risk of having an event associated with elevated blood pressure, even with blood pressure targeted at less than 90 mm Hg, compared with the general population. Aggressive treatment resulted in a 51 percent reduction in risk of heart attack and stroke in the group using 80 mm Hg as a target versus the group using 90 mm Hg as a target.

The addition of aspirin reduced major cardiovascular events by 15 percent and heart attacks specifically by 36 percent.



Physician Referral Online

A free and confidential service
of Yale-New Haven Hospital.

Physician Referral Online
Using your own criteria, you can request information from a database of 900 area physicians who have registered to participate.

Request an appointment
We would be happy to assist you in scheduling an appointment with a member of the hospital's medical staff. Use the link above or call:

203-688-2000
or toll free
1-888-700-6543
to talk with a referral coordinator.



2000 Best Hospital--U.S. News Online

Yale-New Haven was recognized this year by U.S. News & World Report for its programs in cardiology and cardiac surgery.


John F. Setaro, M.D.

Study shows blood pressure control vitally important

The HOT Study, published in British journal The Lancet, was not widely reported in the U.S., but it is a very important study with treatment implications for millions of people. As many as 50 million Americans have high blood pressure, and the numbers are expected to increase as the Baby Boomers approach senior status and as obesity and sedentary lifestyles continue to rise.

"Controlling blood pressure is one of the best things we can do to protect our health."

High blood pressure or hypertension is called the silent killer because it often creates no symptoms until the damage is done. Elevated blood pressure causes the heart to work harder than normal, making both the heart and arteries more prone to injury.

High blood pressure increases risk of:

  • heart attacks
  • strokes
  • kidney failure
  • damage to the eyes
  • congestive heart failure
  • arteriosclerosis

When high blood pressure exists with obesity, smoking, high blood cholesterol levels or diabetes, the risk of heart attack or stroke increases several times.

"Medications. . .are effective in dramatically lowering blood pressure."

The good news is pharmaceutical companies are developing more and better medications to treat high blood pressure, so physicians have more tools to help their patients control high blood pressure. Although medications were not the focus of the HOT Study, its results indicate they are effective in dramatically lowering blood pressure in both men and women from various racial and cultural backgrounds and across a wide age span.

"There are significant health benefits to be gained by bringing [blood] pressure. . .[down] to 138.5/82.6.…"

How low can we go?
Hypertension has been defined as blood pressure of 140/90 or greater, and our goal has been to help patients get their diastolic pressure below that baseline. What the HOT study shows us is that there are significant health benefits to be gained by bringing pressure below that to 138.5/82.6 mm Hg. Cardiovascular complications were 30 percent less likely to occur in the subjects than in populations that were six years younger on average than HOT subjects.

The study also disproved one theory that lowering blood pressure too much might result in worse outcomes for some patients—those with severe heart disease or the very elderly. In fact, although lowering blood pressure further (e.g. 120/70) did not seem to give further benefit, it also did not pose any additional risk even in the 3,000 subjects who showed evidence of significant coronary artery disease.

Many physicians believe it’s unrealistic to try to achieve a diastolic blood pressure below 80, but the study shows that with appropriate medication, blood pressure can be lowered to this level in the majority of patients.

Extra benefits for diabetics
The benefits are even greater for diabetics. Of the 1,501 patients with diabetes, those in the 80 mm Hg group had half the risk of a major stroke or heart attack compared with those in the 90 mm Hg group. The study also found that 75 mg of aspirin in patients with well-controlled blood pressure reduced the risk of heart attack by 36 percent.

What have we learned?

  • Lowering blood pressure to below 140/90 will help patients.
  • Patients with diabetes should be treated more aggressively, bringing blood pressure down to less than 80 if possible.
  • Aspirin is useful in selected hypertensive patients.
  • Calcium channel blockers are generally well tolerated and effective, but it may be necessary to try a combination of drugs on some patients to attain significant reductions in blood pressure.

Controlling blood pressure is one of the best things we can do to protect our health. I advise everyone to have regular blood pressure checks. Regular exercise and weight control will help, but if you are diagnosed with high blood pressure, be sure and talk with your physician about what can be done to reduce it.


Dr. Setaro is an attending cardiologist at Yale-New Haven Hospital and Yale-New Haven Heart Center, as well as an associate professor of medicine and director of the Cardiovascular Disease Prevention Center at the Yale University School of Medicine.


Spacer.
Subscribe to HealthLink.

Other related links.


Copyright 1999-2008.
Top of Page. Y-NHH. YNHHS. Site Editor.

Home page
Staff directory
Directions and parking
Online resources
Yale New Haven Health System
  Need a doctor?
Search
Comments
Top of page